Vector Science and Therapeutics (TSXV:PAIN) EPS without NRI: C$-0.29 (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:PAIN Vector Science and Therapeutics Corp TSXV:PAIN
14 GF Score
Price C$1.55
View Full Analysis

What is Vector Science and Therapeutics EPS without NRI?

Vector Science and Therapeutics TSXV:PAIN -4.32% 14 EPS without NRI is C$-0.29 as of Feb. 2026. GuruFocus rates TSXV:PAIN with a GF Score™ of 14/100. Among 661 Medical Devices & Instruments companies, Vector Science and Therapeutics ranks worse than 151285.78% on this metric.

Vector Science and Therapeutics's earnings per share without non-recurring items for the three months ended in Feb. 2026 was C$-0.08. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was C$-0.29.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Vector Science and Therapeutics's EPS without NRI or its related term are showing as below:

TSXV:PAIN's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 8.2
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Vector Science and Therapeutics's EPS (Diluted) for the three months ended in Feb. 2026 was C$-0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was C$-0.31.

Vector Science and Therapeutics's EPS (Basic) for the three months ended in Feb. 2026 was C$-0.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 was C$-0.31.


Vector Science and Therapeutics  (TSXV:PAIN) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Vector Science and Therapeutics EPS without NRI Related Terms


Vector Science and Therapeutics EPS without NRI Historical Data

* Premium members only.

The historical data trend for Vector Science and Therapeutics's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vector Science and Therapeutics EPS without NRI Chart

Vector Science and Therapeutics Annual Data
Trend Aug24 Aug25
EPS without NRI
0.00 -0.23

Vector Science and Therapeutics Quarterly Data
Aug24 Nov24 Aug25 Nov25 Feb26
EPS without NRI 0.00 0.00 0.00 -0.21 -0.08

TSXV:PAIN vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, Vector Science and Therapeutics's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vector Science and Therapeutics PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vector Science and Therapeutics's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Vector Science and Therapeutics's PE Ratio without NRI falls into.


TSXV:PAIN
14GF Score
Vector Science and Therapeutics Corp TSXV:PAIN
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vector Science and Therapeutics EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of C$-0.29 mean?
Vector Science and Therapeutics (TSXV:PAIN) has a EPS without NRI of C$-0.29 as of Feb. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Vector Science and Therapeutics and its competitors. According to the industry distribution chart, Vector Science and Therapeutics ranks #999999 out of 661 companies in the Medical Devices & Instruments industry.
Is Vector Science and Therapeutics' EPS without NRI too high?
Vector Science and Therapeutics' current EPS without NRI is C$-0.29. Based on the distribution chart, Vector Science and Therapeutics ranks #999999 out of 661 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Vector Science and Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vector Science and Therapeutics' EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vector Science and Therapeutics ranks #999999 out of 661 companies for EPS without NRI. This places Vector Science and Therapeutics in the lower half of its industry. The industry median EPS without NRI is 8.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.20, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Vector Science and Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vector Science and Therapeutics's current EPS without NRI is C$-0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vector Science and Therapeutics stock overvalued right now?
Vector Science and Therapeutics (TSXV:PAIN) has a current EPS without NRI of C$-0.29. The current EPS without NRI is C$-0.29. Vector Science and Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Vector Science and Therapeutics (TSXV:PAIN), the current EPS without NRI is C$-0.29 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vector Science and Therapeutics Business Description

Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
14GF Score

Get the complete analysis for TSXV:PAIN

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.55
Price